Oncology KnowledgeBASE
New Medicine’s Oncology KnowledgeBASE (nm|OK) provides a comprehensive view of the status of the global oncology drug development and personalized medicine sector in terms of:
- companies developing and marketing therapeutic/in vivo imaging agents and/or in vitro diagnostics
- institutions/non-profits with affiliations/agreements in this sector
- therapeutic agents in development or on the market globally (over 4,500 drugs in development)
- molecular targets of approved drugs and of those currently evaluated in preclinical/clinical trials or identified as playing a role in cancer
- patents, orphan drug status, sales, etc.
Sample Company records >
Sample New Drug record >
Sample Marketed Drug Record >
Sample Target Record >
Nm|OK New Drugs and Marketed Drugs profiles >
nm|OK provides detailed profiles of over 5,000 distinct drugs/in vivo imaging agents in development and on the market by
- developer/affiliate (over 1,000 pipelines)
- generic name/brand name/other designation
- technology/class
- mechanism of action
- cancer indications; over 100 indications
- clinical indications; hundreds of indications
- administration route
- molecular target
- biomarker/companion diagnostics
- delivery technology
- development status
- clinical development by phase and status
- clinical history, including trial protocols, interim and final results
- sales history (when available)
nm|OK profiles over 2500 companies in the oncology space in terms of
- history
- management
- financing
- enabling technologies
- affiliations/collaborations/licenses
- pipelines, etc.
nm|OK Targets in Oncology Profiles >
nm|OK profiles over 1,000 molecular targets implicated in cancer and its treatment in terms of
- cancer indication
- utility (treatment, in vivo imaging, in vitro diagnosis, prognosis, disease monitoring
- institution
Future Oncology
From June 1995 to August 2008, New Medicine published Future Oncology, a comprehensive analytical newsletter tracking the evolution of global drug development in oncology.